BRIEF-Proteomics International Laboratories Says Seeks FDA Approval For Promarkerd

Reuters · 02/08/2021 01:26
BRIEF-Proteomics International Laboratories Says Seeks FDA Approval For Promarkerd

- Proteomics International Laboratories Ltd PIQ.AX:

  • SEEKING ADDITIONAL REGULATORY APPROVAL FOR EASY-TO-USE 'KIT' VERSION OF PROMARKERD FOR DIABETIC KIDNEY DISEASE

Source text for Eikon: ID:nASX7GdSJS

Further company coverage: PIQ.AX


((Reuters.Briefs@thomsonreuters.com;))